Ana Sabo
Impact in
-
- Antibiotic Use and Resistance
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Pharmacology 22
- Antibiotics Pharmacokinetics and Efficacy 11
- Inflammatory mediators and NSAID effects 5
-
- Antibiotic Use and Resistance 14
- Co-authors
- Milica Paut Kusturica (17 shared papers)Ana Tomás (22 shared papers)Z. Tomić (33 shared papers)Olga Horvat (31 shared papers)Momir Mikov (13 shared papers)Nebojša Stilinović (10 shared papers)Jovan Popović (3 shared papers)Boris Milijašević (10 shared papers)
- Journals
- International Journal of Clinical Pharmacy (6 papers)Clinical Therapeutics (4 papers)Pharmacoepidemiology and Drug Safety (3 papers)Value in Health (3 papers)Frontiers in Public Health (2 papers)
- Partner nations
- SerbiaUnited StatesMontenegro
In The Last Decade
Ana Sabo
71 papers receiving 766 citations
Peers
Comparison fields: 5 of 127
- Applied Microbiology and Biotechnology 148
- Geriatrics and Gerontology 76
- Family Practice 26
- Pollution 131
- Molecular Medicine 47
Countries citing papers authored by Ana Sabo
This map shows the geographic impact of Ana Sabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Sabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Sabo more than expected).
Fields of papers citing papers by Ana Sabo
This network shows the impact of papers produced by Ana Sabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Sabo. The network helps show where Ana Sabo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Sabo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 100 | |
| 2 | 2012 | 91 | |
| 3 | 2008 | 45 | |
| 4 | 2007 | 34 | |
| 5 | 2016 | 32 | |
| 6 | 2017 | 30 | |
| 7 | 2020 | 28 | |
| 8 | 2012 | 25 | |
| 9 | 2013 | 24 | |
| 10 | 2021 | 22 | |
| 11 | 2010 | 18 | |
| 12 | 2000 | 18 | |
| 13 | 2009 | 18 | |
| 14 | 2018 | 18 | |
| 15 | 2020 | 16 | |
| 16 | 2008 | 16 | |
| 17 | 2011 | 15 | |
| 18 | 2015 | 14 | |
| 19 | 2015 | 14 | |
| 20 | 2010 | 13 |
About Ana Sabo
Ana Sabo is a scholar working on Pharmacology, Applied Microbiology and Biotechnology, Epidemiology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 77 papers that have together received 808 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (7 papers), Pharmaceutical Economics and Policy (6 papers), Pneumonia and Respiratory Infections (5 papers), Pregnancy and Medication Impact (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (148 citations), Geriatrics and Gerontology (76 citations), Family Practice (26 citations), Pollution (131 citations) and Molecular Medicine (47 citations). Ana Sabo has collaborated with scholars based in Serbia, United States and Montenegro. Frequent co-authors include Milica Paut Kusturica, Ana Tomás, Z. Tomić, Olga Horvat, Momir Mikov, Nebojša Stilinović, Jovan Popović, Boris Milijašević, Saša Vukmirović and Ljiljana Tasić. Their work appears in journals such as International Journal of Clinical Pharmacy, Clinical Therapeutics, Pharmacoepidemiology and Drug Safety, Value in Health and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.